HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duramycin radiosensitization of MCA-RH 7777 hepatoma cells through the elevation of reactive oxygen species.

AbstractOBJECTIVE:
The objective of this study is to explore the radiosensitization effects of duramycin against the liver cancer hepatoma cells and relationship to reactive oxygen species (ROS) generation.
MATERIALS AND METHODS:
MCA-RH 7777 cells were treated with various combinations of duramycin concentrations and radiation doses. After the treatment, cell viabilities were determined by a cell proliferation assay; intracellular ROS levels were detected with the flow cytometric method.
RESULTS:
MCA-RH 7777 cell viability was found significantly reduced after combining duramycin and radiation exposure (comparing to that of either treatment alone). Increased intracellular ROS levels were observed in cells treated with combinations of duramycin and radiation.
CONCLUSION:
Duramycin increased the intracellular ROS generation and also increased the radiosensitivity of MCA-RH 7777 cells.
AuthorsBowen Yang, Xiaoke Huang, Weiguo Li, Samdeep Mouli, Robert J Lewandowski, Andrew Christian Larson
JournalJournal of cancer research and therapeutics (J Cancer Res Ther) 2021 Apr-Jun Vol. 17 Issue 2 Pg. 543-546 ISSN: 1998-4138 [Electronic] India
PMID34121705 (Publication Type: Journal Article)
Chemical References
  • Bacteriocins
  • Peptides
  • Radiation-Sensitizing Agents
  • Reactive Oxygen Species
  • duramycin
Topics
  • Apoptosis (drug effects, radiation effects)
  • Bacteriocins (pharmacology, therapeutic use)
  • Carcinoma, Hepatocellular (pathology, therapy)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects, radiation effects)
  • Cell Survival (drug effects, radiation effects)
  • Chemoradiotherapy (methods)
  • Drug Screening Assays, Antitumor
  • Humans
  • Liver Neoplasms (pathology, therapy)
  • Peptides (pharmacology, therapeutic use)
  • Radiation Tolerance (drug effects)
  • Radiation-Sensitizing Agents (pharmacology, therapeutic use)
  • Reactive Oxygen Species (analysis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: